New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome

Current Rheumatology Reports

Volumn 11, Issue 5, 2009, Pages 329-333

  Khan, Muhammad A ^a   Magrey, Marina ^b  

^a METROHEALTH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BISPHOSPHONIC ACID DERIVATIVE; COTRIMOXAZOLE; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; TETRACYCLINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; ZOLEDRONIC ACID;

ACNE; BONE BIOPSY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; EARLY DIAGNOSIS; GENE MUTATION; GENETIC PREDISPOSITION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HYPEROSTOSIS; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; LABORATORY TEST; OSTEOMYELITIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; PROPIONIBACTERIUM ACNES; PUSTULOSIS PALMOPLANTARIS; REVIEW; SAPHO SYNDROME; SUPPURATIVE HIDRADENITIS; SYNOVITIS; WHOLE BODY MRI;

ACNE VULGARIS; ACQUIRED HYPEROSTOSIS SYNDROME; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; HUMANS; HYPEROSTOSIS; MAGNETIC RESONANCE IMAGING; OSTEITIS;

EID: 70449625019     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-009-0047-8     Document Type: Review

References (49)

1. A.M. Chamot C.L. Benhamou M.F. Kahn, et al. 1987 Acne-pustulosis- hyperostosis-osteitis syndrome: results of a national survey-85 cases [in French] Rev Rhum Mal Osteoartic 54 187 196 2954204 1:STN:280: DyaL2s3jtlymuw%3D%3D
2. C.L. Benhamou A.M. Chamot M.F. Kahn 1988 Synovitis-acnepustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol 6 109 112 2972430 1:STN:280: DyaL1M%2FivFejuw%3D%3D
3. M.F. Kahn M.A. Khan 1994 The SAPHO syndrome Baillieres Clin Rheumatol 8 333 362 8076391 10.1016/S0950-3579(94)80022-7 1:STN:280:DyaK2czls12isw%3D%3D (Pubitemid 24189843)
4. B. Bjorksten K.H. Gustavson B. Eriksson, et al. 1978 Chronic recurrent multifocal osteomyelitis and pustulosis palmoplantaris J Pediatr 93 227 231 671154 10.1016/S0022-3476(78)80501-0 1:STN:280:DyaE1c3itVSnug%3D%3D (Pubitemid 8380033)
5. M. Colina M. Govoni C. Orzincolo F. Trotta 2009 Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects Arthritis Rheum 61 813 821 19479702 10.1002/art.24540
6. T. Takigawa M. Tanaka K. Nakanishi, et al. 2008 SAPHO syndrome associated spondylitis Eur Spine J 17 1391 1397 18642032 10.1007/s00586-008-0722-x
7. G. Hayem A. Bouchaud-Chabot K. Benali, et al. 1999 SAPHO syndrome: a long-term follow-up study of 120 cases Semin Arthritis Rheum 29 159 171 10622680 10.1016/S0049-0172(99)80027-4 1:STN:280:DC%2BD3c%2Fos1eqsA%3D%3D
8. M. Govoni M. Colina A. Massara F. Trotta 2009 SAPHO syndrome and infections Autoimmun Rev 8 256 259 18721907 10.1016/j.autrev.2008.07.030 1:CAS:528:DC%2BD1MXmtVyltLg%3D
9. M. Colina A. Lo Monaco M. Khodeir F. Trotta 2007 Propionibacterium acnes and SAPHO syndrome: a case report and literature review Clin Exp Rheumatol 25 457 460 17631745 1:STN:280:DC%2BD2svhtlansg%3D%3D
10. L.G. Delyle O. Vittecoq A. Bourdel, et al. 2000 Chronic destructive oligoarthritis associated with Propionibacterium acnes in a female patient with acne vulgaris: septic-reactive arthritis? Arthritis Rheum 43 2843 2847 11145044 10.1002/1529-0131(200012)43:12<2843::AID-ANR26>3.0.CO;2-2 1:STN:280:DC%2BD3M%2FnvFylug%3D%3D (Pubitemid 32001752)
11. P. Kotilainen R. Merilahti-Palo O.P. Lehtonen, et al. 1996 Propionibacterium acnes isolated from sternal osteitis in a patient with SAPHO syndrome J Rheumatol 23 1302 1304 8823714 1:STN:280:DyaK28vitFSitQ%3D%3D
12. R. Queiro P. Moreno C. Sarasqueta, et al. 2008 Synovitis-acnepustulosis- hyperostosis-osteitis syndrome and psoriatic arthritis exhibit a different immunogenetic profile Clin Exp Rheumatol 26 125 128 18328159 1:STN:280:DC%2BD1c7ntVeguw%3D%3D
13. P.J. Ferguson X. Bing M.A. Vasef, et al. 2006 A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis Bone 38 41 47 16122996 10.1016/j.bone.2005.07.009 1:CAS:528:DC%2BD28Xks1Sn (Pubitemid 43006073)
14. A. Golla A. Jansson J. Ramser, et al. 2002 Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3-18q22 Eur J Hum Genet 10 217 221 11973628 10.1038/sj.ejhg.5200789
15. G. Hayem 2007 Valuable lessons from SAPHO syndrome Joint Bone Spine 74 123 126 17347017 10.1016/j.jbspin.2006.06.006 (Pubitemid 46603014)
16. M. Hurtado-Nedelec S. Chollet-Martin P. Nicaise-Roland, et al. 2008 Characterization of the immune response in the synovitis, acne, pustulosis, hyperostosis, osteitis (SAPHO) syndrome Rheumatology (Oxford) 47 1160 1167 10.1093/rheumatology/ken185 1:CAS:528:DC%2BD1cXoslGhuro%3D (Pubitemid 352038220)
17. P.J. Ferguson M.A. Lokuta H.I. El-Shanti, et al. 2008 Neutrophil dysfunction in a family with a SAPHO syndrome-like phenotype Arthritis Rheum 58 3264 3269 18821685 10.1002/art.23942 1:CAS:528:DC%2BD1cXht12rur3K
18. M.F. Kahn M. Bouvier E. Palazzo, et al. 1991 Sternoclavicular pustulotic osteitis (SAPHO): 20-year interval between skin and bone lesions J Rheumatol 18 1104 1108 1920317 1:STN:280:DyaK38%2FhsFSrsg%3D%3D
19. J.W. Earwaker A. Cotten 2003 SAPHO: syndrome or concept? Imaging findings Skeletal Radiol 32 311 327 12719925 1:STN:280:DC%2BD3s3jvFGnuw%3D%3D
20. J.E. Cabay S. Marcelis R.F. Dondelinger 1998 Inflammatory spondylodiskitis as a unique radiological manifestation of the SAPHO syndrome [in French] J Radiol 79 337 340 9757260 1:STN:280:DyaK1cvivFyitQ%3D%3D
21. R.D. Boutin D. Resnick 1988 The SAPHO syndrome: an evolving concept for unifying several idiopathic disorders of bone and skin AJR Am J Roentgenol 170 585 591
22. S. Van Doornum D. Barraclough G. McColl I. Wicks 2000 SAPHO: rare or just not recognized? Semin Arthritis Rheum 30 70 77 10966214 10.1053/sarh.2000.8371 (Pubitemid 30644074)
23. E. Karadag-Saygi O.H. Gunduz G. Gumrukcu G. Akyuz 2008 SAPHO syndrome: misdiagnosed and operated Acta Reumatol Port 33 460 463 19078862
24. J. Freyschmidt A. Sternberg 1998 The bull's head sign: scintigraphy pattern of sternoclavicular hyperostosis and pustulotic arthrosclerosis Eur Radiol 8 807 812 9601969 10.1007/s003300050476 1:STN:280:DyaK1c3mslemtA%3D%3D
25. J.D. Laredo V. Vuillemin-Bodaghi N. Boutry, et al. 2007 SAPHO syndrome: MR appearance of vertebral involvement Radiology 242 825 831 17244716 10.1148/radiol.2423051222 (Pubitemid 46310096)
26. R. Romanus S. Yden 1952 Destructive and ossifying spondylitic changes in rheumatoid ankylosing spondylitis (pelvospondylitis ossificans) Acta Orthop Scand 22 88 99 13030181 1:STN:280:DyaG3s%2FlsVymug%3D%3D
27. V. Jevtic M. Kos-Golja B. Rozman I. McCall 2000 Marginal erosive discovertebral "Romanus" lesions in ankylosing spondylitis demonstrated by contrast enhanced Gd-DTPA magnetic resonance imaging Skeletal Radiol 29 27 33 10663586 10.1007/s002560050005 1:STN:280:DC%2BD3c7jtVKksg%3D%3D
28. Weber U, Hodler J, Jurik AG, et al.: Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: validation of whole body MRI against conventional MRI. Ann Rheum Dis 2009, May 7 (Epub ahead of print).
29. U. Weber C.W.A. Pfirrmann M.A. Khan 2007 Ankylosing spondylitis: update on imaging and therapy Intl J Adv Rheumatol 5 2 7
30. I. Olivieri A. Padula C. Palazzi 2006 Pharmacological management of SAPHO syndrome Expert Opin Investig Drugs 15 1229 1233 16989598 10.1517/13543784.15. 10.1229 1:CAS:528:DC%2BD28XpvVeisbY%3D (Pubitemid 44608261)
31. S. Kalke S.D. Perera N.D. Patel, et al. 2001 The sternoclavicular syndrome: experience from a district general hospital and results of a national postal survey Rheumatology (Oxford) 40 170 177 10.1093/rheumatology/40.2.170 1:STN:280:DC%2BD3MzisVaksw%3D%3D
32. N. Pennanen S. Lapinjoki A. Urtti J. Monkkonen 1995 Effect of liposomal and free bisphosphonates on the IL-1a, IL-6, and TNFα secretion from RAW264 cells in vitro Pharm Res 12 916 22 7667201 10.1023/A:1016281608773 1:CAS:528:DyaK2MXmtFSjsro%3D
33. W.P. Maksymowych 2003 Bisphosphonates for arthritis-a confusing rationale J Rheum 30 430 434 12610795
34. M. Colina R. La Corte F. Trotta 2009 Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature Clin Exp Rheumatol 27 112 125 19327238 1:STN:280: DC%2BD1M3ktV2jtQ%3D%3D
35. H. Amital Y.H. Applbaum S. Aamar, et al. 2004 SAPHO syndrome treated with pamidronate: an open-label study of 10 patients Rheumatology (Oxford) 43 658 661 10.1093/rheumatology/keh149 1:CAS:528:DC%2BD2cXjsVektbk%3D (Pubitemid 38628200)
36. H. Marshall J. Bromilow A.L. Thomas N.K. Arden 2002 Pamidronate: a novel treatment for the SAPHO syndrome? Rheumatology 41 231 233 11886977 10.1093/rheumatology/41.2.231-a 1:STN:280:DC%2BD387lsFWhug%3D%3D
37. S. Guignard C. Job-Deslandre V. Sayag-Boukris A. Kahan 2002 Pamidronate treatment in SAPHO syndrome Joint Bone Spine 69 392 396 12184437 10.1016/S1297-319X(02)00419-0 1:STN:280:DC%2BD38vivVWitw%3D%3D (Pubitemid 34823833)
38. P.A. Courtney D.J. Hosking K.J. Fairbairn C.M. Deighton 2002 Treatment of SAPHO with pamidronate Rheumatology 41 1196 1198 12364646 10.1093/rheumatology/ 41.10.1196 1:STN:280:DC%2BD38nhtVSntQ%3D%3D
39. C. Kerrison J.E. Davidson A.G. Cleary M.W. Beresford 2004 Pamidronate in the treatment of childhood SAPHO syndrome Rheumatology 43 1246 1251 15238641 10.1093/rheumatology/keh295 1:CAS:528:DC%2BD2cXnvVOrur8%3D (Pubitemid 39359298)
40. P. Kopterides D. Pikazis C. Koufos 2004 Successful treatment of SAPHO syndrome with zoledronic acid Arthritis Rheum 50 2970 2973 15457466 10.1002/art.20464 (Pubitemid 39209536)
41. A. Just S. Adams T. Brinkmeier, et al. 2008 Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates [in German] J Dtsch Dermatol Ges 6 657 660 18266863 10.1111/j.1610-0387.2008.06588.x
42. A.D. Wagner J. Andresen M.C. Jendro, et al. 2002 Sustained response to tumor necrosis factor a-blocking agents in two patients with SAPHO syndrome Arthritis Rheum 46 1965 1968 12124882 10.1002/art.10539 (Pubitemid 34774530)
43. I. Olivieri A. Padula G. Ciancio, et al. 2002 Successful treatment of SAPHO syndrome with infliximab: report of two cases Ann Rheum Dis 61 375 376 11874849 10.1136/ard.61.4.375 1:STN:280:DC%2BD387jvVOksw%3D%3D (Pubitemid 34257756)
44. M. Iqbal M.S. Kolodney 2005 Acne fulminans with synovitisacne-pustulosis- hyperostosis-osteitis (SAPHO) syndrome treated with infliximab J Am Acad Dermatol 52 S118 S120 15858507 10.1016/j.jaad.2004.09.006
45. A. Deutschmann C.J. Mache K. Bodo, et al. 2005 Successful treatment of chronic recurrent multifocal osteomyelitis with tumor necrosis factor-a blockage Pediatrics 116 1231 1233 16264014 10.1542/peds.2004-2206 (Pubitemid 46056433)
46. A. Massara P.L. Cavazzini F. Trotta 2006 In SAPHO syndrome anti-TNF-a therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations Rheumatology 45 730 733 16403830 10.1093/rheumatology/kei221 1:CAS:528:DC%2BD28Xmt1Wkurk%3D (Pubitemid 43985342)
47. F. Schilling A.D. Wagner 2000 Azithromycin: an anti-inflammatory effect in chronic recurrent multifocal osteomyelitis? A preliminary report [in German] Z Rheumatol 59 352 353 10.1007/s003930070059 1:STN:280:DC%2BD3M7htl2ruw%3D%3D
48. S.C. Ballara Q.H. Siraj R.N. Maini P.J. Venables 1999 Sustained response to doxycycline therapy in two patients with SAPHO syndrome Arthritis Rheum 42 819 821 10211901 10.1002/1529-0131(199904)42:4<818::AID-ANR29>3.0.CO;2-G 1:STN:280:DyaK1M3is1yrsQ%3D%3D
49. A.P. Rozin A.M. Nahir 2007 Is SAPHO syndrome a target for antibiotic therapy? Clin Rheumatol 26 817 820 16601916 10.1007/s10067-006-0274-6 1:STN:280:DC%2BD2s7pvVOnsA%3D%3D (Pubitemid 46554104)